Induction of Labor at 40 Weeks of Gestation after Dissemination of the ARRIVE Trial

The ARRIVE trial showed that induction of labor in low-risk nulliparous individuals at 39 weeks reduced cesarean delivery. We sought to determine whether publication of the ARRIVE trial was associated with changes in the rate of induction of labor at 40 weeks, and if so, whether similar changes were seen in the rate of cesarean delivery.This was a repeated cross-sectional analysis using US natality data from February 2017 to August 2019. Low-risk nulliparous individuals delivering a non-anomalous, cephalic, singleton infant were included; exclusion criteria included hypertension, diabetes, or small-for-gestational age infant. The primary outcome was induction of labor at 40 weeks. Secondary outcomes included cesarean delivery and a composite of adverse neonatal outcomes. A population-level interrupted time series analysis was performed. The pre-period ran from February 2017 to January 2018, the dissemination period from February to August 2018, and the post-period from September 2018 to August 2019.The study included 843,133 individuals (339,978 in the pre-period; 190,479 in the dissemination or washout period; 312,676 in the post-period). The rate of induction of labor at 40 weeks increased from a predicted rate of 18.7% to an observed rate of 20.2% (IRR, 1.08, 95% CI: 1.05-1.12) in the post-period. The rate of cesarean delivery and adverse neonatal outcomes in the cohort did not change at the start of the post-period (cesarean delivery: 25.3% predicted vs. 25.2% observed, IRR, 1.00, 95% CI: 0.96-1.03; adverse neonatal outcome: 5.3% predicted vs. 5.0% observed, IRR, 0.95, 95% CI: 0.87-1.02).Dissemination of the ARRIVE trial was associated with an increase in the rate of induction at 40 weeks among patients who remained pregnant after 39 weeks. However, there was no population-level decrease in cesarean delivery, suggesting that the benefits of induction of labor may not extrapolate to this cohort. · The ARRIVE trial increased low-risk induction of labor at 40 weeks of gestation.. · Increasing 40-week induction rates did not correspond to lower rates of cesarean delivery.. · Offering induction at 40 weeks is reasonable given no associated increase in adverse outcomes..

Authors

Institutions

Publication Details

Journal
American Journal of Perinatology
Published
2025-10-17
DOI
https://doi.org/10.1055/a-2716-1855
Primary Topic
Maternal and Perinatal Health Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Induction of Labor at 40 Weeks of Gestation after Dissemination of the ARRIVE Trial

Alexander Melamed, Taylor S. Freret, Mark A. Clapp, Anjali J Kaimal
American Journal of Perinatology
Maternal and Perinatal Health Interventions
article

Induction of Labor at 40 Weeks of Gestation after Dissemination of the ARRIVE Trial

Alexander Melamed, Taylor S. Freret, Mark A. Clapp, Anjali J Kaimal
article en

Abstract

The ARRIVE trial showed that induction of labor in low-risk nulliparous individuals at 39 weeks reduced cesarean delivery. We sought to determine whether publication of the ARRIVE trial was associated with changes in the rate of induction of labor at 40 weeks, and if so, whether similar changes were seen in the rate of cesarean delivery.This was a repeated cross-sectional analysis using US natality data from February 2017 to August 2019. Low-risk nulliparous individuals delivering a non-anomalous, cephalic, singleton infant were included; exclusion criteria included hypertension, diabetes, or small-for-gestational age infant. The primary outcome was induction of labor at 40 weeks. Secondary outcomes included cesarean delivery and a composite of adverse neonatal outcomes. A population-level interrupted time series analysis was performed. The pre-period ran from February 2017 to January 2018, the dissemination period from February to August 2018, and the post-period from September 2018 to August 2019.The study included 843,133 individuals (339,978 in the pre-period; 190,479 in the dissemination or washout period; 312,676 in the post-period). The rate of induction of labor at 40 weeks increased from a predicted rate of 18.7% to an observed rate of 20.2% (IRR, 1.08, 95% CI: 1.05-1.12) in the post-period. The rate of cesarean delivery and adverse neonatal outcomes in the cohort did not change at the start of the post-period (cesarean delivery: 25.3% predicted vs. 25.2% observed, IRR, 1.00, 95% CI: 0.96-1.03; adverse neonatal outcome: 5.3% predicted vs. 5.0% observed, IRR, 0.95, 95% CI: 0.87-1.02).Dissemination of the ARRIVE trial was associated with an increase in the rate of induction at 40 weeks among patients who remained pregnant after 39 weeks. However, there was no population-level decrease in cesarean delivery, suggesting that the benefits of induction of labor may not extrapolate to this cohort. · The ARRIVE trial increased low-risk induction of labor at 40 weeks of gestation.. · Increasing 40-week induction rates did not correspond to lower rates of cesarean delivery.. · Offering induction at 40 weeks is reasonable given no associated increase in adverse outcomes..

American Journal of Perinatology
Beth Israel Deaconess Medical Center (US), University of South Florida (US), Massachusetts General Hospital (US)
Openalex Percentile: Top 63%
Maternal and Perinatal Health Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.